Prothena reported 3.21B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Adamas Pharmaceuticals ADMS:US 223.88M 15.88M
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Akebia Therapeutics AKBA:US $ 502.67M 104.17M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
ALKERMES ALKS:US 4.98B 1.04B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Exelixis EXEL:US $ 6.66B 950.22M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Intra Cellular Therapies ITCI:US $ 3.03B 286.74M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Macrogenics MGNX:US $ 1.28B 335.6M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Prothena PRTA:US 3.21B 937.65M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
Vital Therapies VTL:US $ 232.31M 34.34M
Xoma XOMA:US $ 279.95M 104.59M
YTE INCY:US $ 15.19B 3.31B